HospitalsAescia for Hospitals is an investigational Software as a Medical Device under the TGA Class IIa pathway. Not yet available for commercial supply.
ClinicsAescia for Clinics is a workflow and patient-preparation tool. It does not propose clinical decisions and is not a medical device.
Pre-procedure pathways by text and email, with endoscopy as the first home. Diabetic, anticoagulant, and GLP-1 overlays. Recall that stops slipping. It does not propose clinical decisions and is not a medical device.
Post-surgical recovery monitoring, built first for cardiothoracic surgery. Daily check-ins, clinician-authored prioritisation, one list for the nursing team. In clinical evaluation through the SAFE-Discharge trial.
of surveillance patients never return on time
Cooper 2013, n=12,771
of real-world colonoscopies arrive with inadequate prep
US midpoint; USMSTF benchmark is 90% adequate
combined no-shows and late cancellations
ASGE benchmark, 5.6–8.45%
Trial data is stored in Australia (Amazon Web Services Sydney region, through Supabase). For planned United States deployments, customer data would be hosted on Google Cloud in the United States, under a Business Associate Agreement (BAA) signed before any patient data moves.
Read the security pageStart with manual entry or a simple export. No integration required to begin. Deeper data exchange is scoped with you.
How we start with youConservative, expected, and better-case bands. Every input cited, from prep-coaching trials to 17,052 real ASC facility fees. No point estimates; assumptions visible.
Open the calculatorAescia for Clinics has no customers yet. A small named set of ASCs, outcomes pre-specified in writing, measured against your own baseline, adjudicated by your QA committee.
Read the program termsPre-procedure pathways by text and email. Diabetic, anticoagulant, and GLP-1 overlays. Fewer phone calls to the front desk.
Aescia for ClinicsDaily check-ins after cardiothoracic surgery. Clinician-authored rules turn them into one prioritised list for the nursing team.
Aescia for HospitalsEvery pathway is a sequence of five step types. One engine, built once, applied to the two moments care most often falls apart: the week after discharge, and the week before a procedure.
Structured patient signal. Photo, scale, questionnaire, vitals, timestamped.
A clinician-authored rule reads the signal and flags for the clinician. Every rule explainable.
Timed outbound prompt by SMS, email, or in-app, in the patient's language.
A clinician-written PDF, video, or card delivered at the right moment.
A structured, consented, time-stamped record ready for the patient's chart.
One engine · five step types · every pathway
Structured patient signal. Photo, scale, questionnaire, vitals, timestamped.
A clinician-authored rule reads the signal and flags for the clinician. Every rule explainable.
Timed outbound prompt by SMS, email, or in-app, in the patient's language.
A clinician-written PDF, video, or card delivered at the right moment.
A structured, consented, time-stamped record ready for the patient's chart.
Rule-based prioritisation, authored by clinicians. No opaque models. Every flag is explainable to the nurse it lands with and to the committee that asks.
Pathways are written by practising surgeons, gastroenterologists, and nurses. We do not ship a disease we did not learn from the people who treat it.
A regulated pathway for surgical recovery and a workflow pathway for procedural clinics share the same authoring layer and the same team.
Aescia for Hospitals has been in a live trial at Royal Prince Alfred Hospital since June 2026, with good early results. SAFE-Discharge evaluates post-surgical monitoring in the hospital's cardiothoracic unit in Sydney. Dr Kei Woldendorp is the Principal Investigator, and Sydney Local Health District sponsors the trial.
Read the evidence pageAescia is in a live trial at the Royal Prince Alfred Hospital cardiothoracic unit in Sydney, with research collaborations across named institutes in Australia and Canada. We publish affiliations we have earned, not logo walls.
Royal Prince Alfred Hospital
Sydney Local Health District tertiary teaching hospital. Cardiothoracic surgical unit hosts the SAFE-Discharge trial site.
(opens in a new window)The Baird Institute
Independent cardiothoracic surgical research institute affiliated with RPAH. Co-investigator on SAFE-Discharge.
(opens in a new window)Institute of Academic Surgery
RPAH academic surgery research and education hub. Provides governance pathway for the SAFE-Discharge implementation evaluation.
(opens in a new window)CHEO Research Institute
Children's Hospital of Eastern Ontario research arm in Ottawa. Aescia is a selected participant in its Product-Market-Fit (PMF) programme, working on a paediatric respiratory post-discharge pathway.
(opens in a new window)District 3
Quebec's leading bio/health/tech startup incubator at Concordia University, Montréal. Aescia portfolio company since September 2025.
(opens in a new window)MTAA MedTech Compass
Medical Technology Association of Australia capability programme for emerging medical-device companies. Aescia industry member.
(opens in a new window)A thirty-minute call with the clinical team. We show the worklist, the pathway editor, the week after surgery and the night before a colonoscopy.
Request a briefing